To investigate the clinical and bacteriological efficacy of Fucidin® cream in the treatment
of impetigo in paediatric patients.
To assess the validity of in vitro susceptibility-testing of S. aureus to fusidic acid as a
prediction of clinical and bacteriological outcome in impetigo patients treated with Fucidin®
cream.
To investigate the genetic relationship between S. aureus-strains isolated from impetigo
patients.